Article: Judge Rules Generic Version of Paxil Drug Does Not Infringe on Glaxo's Patent.

By Linda Loyd, The Philadelphia Inquirer Knight Ridder/Tribune Business News

Mar. 5--GlaxoSmithKline P.L.C. lost an important court case involving its top-selling drug when a federal judge in Chicago ruled that a Canadian drug maker's generic version of Paxil did not infringe on Glaxo's original patent.

The ruling means that Apotex Inc. may be able to sell a generic version of the antidepressant Paxil, even though Glaxo's patent doesn't expire until 2006.

U.S. Judge Richard Posner said the chemical form of Apotex's version of Paxil differed and did not violate Glaxo's patent on the drug, known by the chemical name paroxetine ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!